PetMed Express, Inc. Sets Fiscal Third Quarter 2024 Earnings Call
DELRAY BEACH, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) — PetMed Express, Inc. (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health […]
First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial
PASADENA, CA, Jan. 29, 2024 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”), […]
Bitdeer Announces Appointment of Jihan Wu as New Chief Executive Officer as Linghui Kong Transitions to Chief Business Officer
SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company […]
Citizens Community Bancorp, Inc. Reports 4Q2023 Earnings of $0.35 Per Share;
Common Equity Increases 5%; Deposits Grew $46 million;Board of Directors Increase Annual Dividend 10% to $0.32 Per Share EAU CLAIRE, […]
IES Holdings Announces Fiscal 2024 First Quarter Results Earnings Release Schedule
HOUSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced that […]
Trust Stamp Announces Alliance with ManTech to Provide AI-Powered Identity Management Technology
ATLANTA, Jan. 29, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI) today announced a Teaming Agreement with ManTech to integrate […]
Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer
SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and […]
Privia Health Appoints Edward C. Fargis as General Counsel
ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) announced that Edward C. Fargis has […]
New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million Commitment from External Investors
COPENHAGEN, Denmark, Jan. 29, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced the formation and launch with […]
TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively […]
